Clinical Trial of TQB2868 Injection in Subjects With Advanced Malignant Tumors
NCT05198505
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
280
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Malignant Tumor
Interventions
DRUG:
TQB2868 Injection
Sponsor
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.